ALLO icon

Allogene Therapeutics
ALLO

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$6.5
292% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Citizens
Citizens
Reni Benjamin
50% 1-yr ALLO win rate
9 Jan ‘26 6 days ago
UBS
UBS
Michael Yee
100% 1-yr ALLO win rate
7 Jan ‘26 8 days ago